Overview of Driclor

Defining Driclor: Identity and Pharmacological Class

Property	Description
Active ingredient	Aluminium Chloride Hexahydrate
Form	Topical solution (Roll-on)
Pharmacological class	Strong Antiperspirant, Astringent Agent
Common use	Management of Excessive Sweating (Hyperhidrosis)
Origin	Synthetic aluminium salt compound

Driclor is defined as a potent topical antiperspirant solution primarily utilized for the control of excessive sweating, known clinically as hyperhidrosis. Its primary therapeutic agent is Aluminium Chloride Hexahydrate, which is classified as an Astringent Agent. This formulation is recognized for its high efficacy, often considered a first-line non-surgical treatment for hyperhidrosis, representing a foundational treatment option for individuals with persistent heavy perspiration.

Composition, Form, and Origin

The product's effectiveness stems from its single active component, Aluminium Chloride Hexahydrate, which is a synthetic aluminium salt compound. Driclor is supplied as a clear liquid solution, typically utilizing a convenient roll-on applicator for direct topical administration. The active salt is dissolved in a hydro-alcoholic base that includes both Ethanol (Ethyl alcohol) and Purified Water. This base is critical for ensuring the stable delivery of the high-concentration salt to the skin surface, making it suitable for adults and adolescents experiencing significant perspiration.

The General Purpose of Driclor

The fundamental purpose of Driclor is to provide potent and localized perspiration control by creating a physical barrier against sweat release. It is generally used to help manage the symptoms of hyperhidrosis in focal areas such as the armpits, hands, or feet where standard antiperspirants are insufficient. Topical aluminium chloride is considered a treatment of choice for local hyperhidrosis. Consequently, the product's role is to offer effective dryness and comfort to patients experiencing medically significant levels of moisture output.

What side effects are possible with Driclor?

Possible Side Effects and Safety Information

The safety profile of topical Aluminium Chloride Hexahydrate (Driclor) is primarily defined by localized dermatological reactions occurring at the application site, as classified in official regulatory documents. Adverse events are overwhelmingly categorized under the Skin and subcutaneous tissue disorders system-organ class.

Officially Documented Adverse Reactions

The most frequent adverse events are linked to the potent astringent nature of the solution. Based on regulatory patient information, side effects are classified by frequency:

Common: Local skin irritation, burning sensation, redness (erythema), and itching (pruritus) at the application site.
Uncommon: Local rash, swelling, and the formation of blisters.

Serious adverse events documented in safety information include signs of a severe allergic reaction (hypersensitivity), such as widespread hives, swelling of the face, tongue, or throat, or difficulty breathing. Intense, persistent local burning or irritation beyond expected transient discomfort is also considered a significant reaction.

Population and Contextual Safety Constraints

Official labeling contains specific constraints regarding use and certain patient populations:

Kidney Disease: Regulatory documents, such as those from the FDA, advise that individuals with kidney disease should consult a health professional before using the product.
Skin Condition Restriction: The solution is approved only for application to intact, dry skin. It must not be applied to skin that is broken, cut, irritated, or recently shaved to prevent severe local reactions. Contact with the eyes or other mucous membranes is explicitly restricted.

Overdose and Emergency Response

The topical application of Driclor Solution, containing aluminum chloride hexahydrate, is not associated with typical overdose symptoms described for systemically acting medications. The primary risks detailed in official product information relate to accidental misuse or ingestion.

Accidental Ingestion

Accidental swallowing of the product can be potentially harmful, especially in children, and may result in injury to the digestive tract due to the corrosive nature of aluminum chloride in the presence of water. The product labeling explicitly directs users to keep the solution out of the reach of children.

If Driclor is swallowed, immediately contact a healthcare provider, poison control center, or seek emergency medical help. This is considered a medical emergency.

Symptoms of Accidental Exposure

Exposure Context	Required Immediate Action (Official Statements)
Swallowing (Ingestion)	Call your healthcare provider or get medical help immediately.
Accidental Eye/Mouth Contact	Rinse the affected area well with water.

For external contact with sensitive areas, such as the eyes, nostrils, or mouth, the product's strong irritant properties may cause a severe local reaction. Should accidental contact occur in these areas, thorough rinsing with water is required to manage the exposure. Any signs of an allergic reaction, such as swelling or difficulty breathing, also warrant immediate medical attention.

Therapeutic Uses of Driclor

Driclor is generally applied when additional symptomatic support for localized relief from the symptoms of excessive sweating is needed, a condition also known as hyperhidrosis. Its active ingredient is considered relevant within clinical settings that involve acute or disruptive symptom patterns associated with hyperhidrosis.

Key Therapeutic Focus

The medication is relevant for managing symptoms that interfere with daily comfort, particularly in the context of primary focal hyperhidrosis. It is commonly used to help manage excessive perspiration in specific anatomical sites, including the underarms (axillary), hands (palmar), and feet (plantar). Driclor is generally applied in situations where patients experience medically significant levels of moisture that overwhelm standard antiperspirants.

“The treatment helps address symptom clusters that may become intense or disruptive, and may be part of symptomatic management for high-volume moisture output.”

The primary therapeutic benefit is that it supports perspiration control and contributes to easing the overall symptom load during periods of heightened symptoms in areas of heightened physiological activity. This supportive symptomatic control assists with maintaining functional stability and contributes to easing the overall symptom load during episodes of heightened discomfort.

Quick Fact: Relief for Excessive Focussed Moisture

Functional and Symptomatic Relief

Driclor is relevant for managing symptom clusters that may become intense or disruptive, helping to address the consequential symptoms that arise from persistent heavy sweating. It assists with maintaining functional stability by supporting the reduction of functional impairments such as a slippery grip. Furthermore, the management of these physical symptoms may assist with reducing the patient's discomfort and emotional tension.

Regulatory References

NHS Tayside Clinical Guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Driclor?

This section outlines the official population eligibility rules for Driclor, based strictly on governmental regulatory documents.

Contraindications and Restrictions

Population Status	Eligibility Rule
Absolute Contraindication	Individuals with known hypersensitivity or allergy to Aluminium Chloride Hexahydrate or any other ingredient in the formulation must not use the product.
Application Site Exclusion	The solution must not be applied to skin that is broken, irritated, or recently shaved (within 12 hours), as this establishes a temporary state of non-eligibility for the affected area.

Specific Population Eligibility

Population Group	Regulatory Status
General Use	Use is generally established for Adults, Adolescents, and The Elderly.
Pediatric Use	The product is not recommended for use by children under 3 years of age.
Pregnancy	Some regulatory documents indicate no specific restrictions for use during pregnancy.
Lactation	Conditional use is required; breastfeeding women must avoid application to the breast area and wash off all traces before feeding.
Renal Impairment	Patients with kidney disease should consult a clinician before use due to the possibility of increased systemic absorption.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Driclor (Aluminium Chloride Hexahydrate, Topical Solution) primarily based on its local application and minimal systemic absorption.

Systemic Drug Interaction Status

No systemic drug-drug interactions are known or formally documented in regulatory labels for topical Aluminium Chloride Hexahydrate. Co-administration of oral or injectable medicines is not formally restricted, as the product is designed to act locally on the skin surface with negligible absorption into the bloodstream. Furthermore, no specific interactions with food, alcohol, or herbal products are documented in official prescribing information.

Local Co-administration and Administration Timing

The profile is defined by local restrictions intended to protect skin integrity and prevent excessive local exposure:

Local Pharmacodynamic Restriction: Co-administration of other antiperspirants or deodorants on the same treated area is restricted to avoid local skin irritation or over-treatment.
Mandatory Timing Rule: The product must not be applied to skin that has been shaved or treated with hair removal products within the 12 hours before or after use.

Population Exposure Precaution

A pharmacokinetic consideration is noted for individuals with renal impairment. Absorbed aluminum is cleared by the kidneys, and reduced renal function poses a potential risk for increased systemic aluminum exposure due to decreased clearance. This is a documented precaution related to the elimination pathway of absorbed product.

Mechanism of Action

How Driclor Works: Mechanism of Action

Physical Blockade of the Eccrine Duct Lumen

The drug's primary action is a physical obstruction mechanism targeting the eccrine sweat duct lumen. The active ingredient, aluminum chloride hexahydrate, penetrates the duct and reacts with proteins and moisture present in the sweat. This chemical interaction results in the precipitation of an insoluble metallic salt-protein complex, which forms a dense, crystalline intraluminal plug . This mechanism directly prevents the flow of fluid from the gland to the skin surface, leading to a reduction in transepidermal moisture flow.

Structural Reinforcement and Fluid Dynamics

The presence of the physical obstruction initiates a secondary cellular response. The epithelial cells lining the sweat duct swell and change shape, which reinforces the initial plug and contributes to a more stable barrier. This localized action results in the sustained occlusion of the duct. Consequently, the sweat produced by the gland is rerouted and reabsorbed into the surrounding periglandular tissue and bloodstream. This fluid reabsorption modulates sudomotor function by reducing the externalized flow from the eccrine glands.

Dosage and Administration Information

Administration Guidelines

Driclor is a potent topical solution containing Aluminium Chloride Hexahydrate 20% w/w, designated for application only to focal sites of excessive perspiration, primarily the axillae, hands, or feet. The administration follows a two-phase schedule to achieve and maintain adequate control.

Administration Schedule

Administration Phase	Frequency and Duration
Initial Phase	Applied once daily at night before sleep. This continues until daytime perspiration is clinically controlled.
Maintenance Phase	Frequency is reduced to an intermittent schedule, typically once or twice weekly or as needed to sustain the effect.

Key Procedural Requirements

Proper use is strictly conditioned on the state of the skin and the time of application. The application area must be thoroughly dry prior to use to ensure proper function. Application must occur at night because sweat glands are least active, thereby maximizing the solution’s effect. It is mandatory to wash the product off completely with water and soap the following morning; the product must not be reapplied during the day.

The label specifies that the product should not be used on any skin that is broken, irritated, or recently shaved (within 12 hours). The standard regimen is defined for adults and adolescents, and the formulation is also suitable for children over 3 years of age. This structured process transitions from daily therapeutic application to an intermittent long-term maintenance cycle to align with usage guidelines.

Recent Clinical Evidence

Research evidence / Overview of studies for Driclor

Evidence for Use in Managing Underarm (Axillary) Sweating

Research was studied for excessive underarm sweating, known as primary axillary hyperhidrosis, and includes both controlled clinical trials and large observational studies. Researchers primarily focused on outcomes related to physical discomfort and functional limitations. The studies monitored changes in symptom intensity and patient-reported outcomes describing perceived discomfort. These trials report how symptoms evolved in the observed populations during defined time intervals.

The body of research for axillary application is available for review. Research describes short-term changes, but there is limited information for long-term outcomes. Follow-up durations were limited in many initial trials, meaning the long-term effects are not fully established.

Evidence for Use in Managing Hand (Palmar) Sweating

Studies examined the use of the solution for excessive hand sweating, or primary palmar hyperhidrosis, which are generally smaller in scale. Research was evaluated in small randomized trials. Studies report how symptoms evolved in the observed populations during the short-term study period. Findings indicate that local skin reactions and irritation were frequently observed in some studies, which was associated with patient adherence. Comparative evidence is lacking against non-topical treatments for this site.

Evidence Gaps and Areas of Scientific Uncertainty

The research describes what has been evaluated and what remains uncertain. The primary area of uncertainty documented in the scientific literature relates to the high rate of skin irritation observed in studies and the resulting impact on patient adherence. Sample sizes were modest in many trials, and the evidence quality varies across studies and the different body areas studied. Data for certain groups such as older adults, pregnant individuals, or those with complex comorbidities, remain insufficient.

Key Studies & References

Guidance on the Management of Primary Hyperhidrosis (Axillary, Palmar, Plantar)

Frequently Asked Questions (FAQ)

Common questions about Driclor (FAQ)

Q: Why does Driclor often cause irritation or discomfort if the application area is wet?

Regulatory warnings state that the skin must be completely dry before applying Driclor. When the strong aluminum chloride solution encounters moisture on the skin, it can react chemically, a process that regulatory warnings describe as leading to local irritation, stinging, and burning. The dry condition is necessary to minimize the risk of local irritation.

Q: What should a person do if irritation or redness persists after reducing the frequency of application?

Patient information indicates that if severe or persistent irritation or redness occurs, discontinuation of the product's use may be necessary. Official documents describe that in such cases, consultation with a health professional is advised to determine the next appropriate steps.

Q: Can Driclor be safely applied to other parts of the body, such as the face, neck, or groin?

The official product information states Driclor is indicated for focal application on the armpits, hands, and feet. The regulatory documents only indicate use for these areas, and warnings explicitly restrict use on the eyes and mucous membranes. Sites such as the face, neck, or groin are not listed as indicated areas of application.

Q: What official guidance is provided on the long-term use and safety of aluminum chloride antiperspirants?

Research summaries in regulatory documents indicate that while studies describe short-term effects, there is limited information available on outcomes and safety for long-term use. The long-term effects are therefore not fully established, which highlights an area of scientific uncertainty noted within the regulatory framework.

Q: Are there any documented interactions between Driclor and other topical skin products or moisturizers?

Regulatory information restricts co-administration with other antiperspirants or deodorants on the same treated site to minimize local irritation. There are no documented systemic drug interactions. However, topical interactions with non-antiperspirant products, such as general skin moisturizers, are not specifically addressed in official interaction sections.

Q: Can a regular scented deodorant or fragrance be used in the morning after using Driclor at night?

The official product information states that Driclor must be washed off completely with soap and water in the morning. While regulatory warnings restrict the co-administration of deodorants during the application period (at night), they do not restrict the use of a fragrance or standard deodorant after washing off the product.

Q: What should a user do if Driclor accidentally contacts sensitive areas like the eyes, mouth, or nostrils?

Official warnings describe that if contact occurs with the eyes or other mucous membranes (such as the mouth or nostrils), the affected area is to be rinsed thoroughly with water. This action is described in the product's safety information.

Q: Is Driclor's mechanism of blocking sweat glands considered safe for the body's overall health?

The product's action is highly localized to the sweat gland, and systemic absorption is described in regulatory documents as negligible. Official warnings focus on local dermatological reactions and a specific precaution for individuals with kidney disease. Consultation with a clinician is advised for those with known kidney impairment.

Q: Does Driclor require a dry application area to prevent chemical irritation?

Regulatory texts mandate application to a completely dry area for two purposes: to ensure the product functions properly by forming the sweat plug, and to minimize the risk of local irritation that occurs when the solution reacts with moisture.

Q: Can Driclor be used on hands and feet, and does the application method differ for these areas?

The product is officially indicated for use on the armpits, hands, and feet. The official administration guidelines provide one two-phase schedule for application to all treated sites. The regulatory documents do not specify a different application method for the hands or feet compared to the armpits.

Q: Can Driclor potentially stain or damage clothing if it is not allowed to dry completely?

Regulatory warnings state that the product can potentially stain clothes and fabrics. For this reason, the product labeling states that the solution must be allowed to dry completely before dressing.

Q: Can Driclor be used by people with sensitive skin?

Official documents describe local irritation and burning as common adverse reactions to the product. Individuals with conditions that cause skin barrier disruption, such as broken or irritated skin, are excluded from use, as this increases the likelihood of a severe reaction.

Q: Is Driclor classified as a cosmetic product, an over-the-counter medicine, or a prescription medicine?

Regulatory classification varies by country. In several regions, including the UK, the product is classified as a pharmacy medicine (P). This means it is a licensed pharmaceutical product that is not considered a cosmetic, but can typically be obtained without a doctor's prescription under the supervision of a pharmacist.

Q: Is Driclor effective for managing excessive sweating (hyperhidrosis) that is caused by stress or anxiety?

Product information describes the use of Driclor for the management of excessive perspiration (hyperhidrosis). The regulatory scope and described therapeutic effects do not distinguish between hyperhidrosis caused by emotion (such as stress or anxiety) or other underlying causes.

Q: Can Driclor be used to help reduce body odor (bromhidrosis) as well as wetness?

The product is officially indicated and described in regulatory texts to control excessive perspiration or wetness. Regulatory text does not include bromhidrosis (body odor) in the list of indications or the described therapeutic effects.

Q: What is the risk of accidental contact with clothing or polished surfaces?

Regulatory warnings state that the product can stain clothes and fabrics. Product labeling indicates that it must be allowed to dry completely before dressing. However, the warnings do not address the potential risk of accidental contact with other polished surfaces or metal jewelry.

How should Driclor be stored and disposed of?

Storage and Disposal Requirements for Driclor

Driclor Solution must be stored in a cool place, specifically at a temperature below 25 C (77 F), and must be kept in an upright position. Due to the hydro-alcoholic base, the product is flammable and must be stored away from any naked flame or sources of ignition.

Container and Security

The medicine must be kept in its original carton, and the cap must be screwed on firmly after use to secure the rollerball. Like all medicines, the product must be kept out of the sight and reach of children. The solution must not be used past the expiry date printed on the packaging.

Disposal of Unused Product

Regulatory guidance states that unused or expired Driclor must not be thrown away via wastewater or household waste. Disposal must be handled according to local instructions for pharmaceutical waste to ensure environmental safety.

Driclor